Management of Type 1 Diabetes with Overnight Hypoglycemia Risk

Immediate Dose Adjustment

The American Diabetes Association recommends decreasing basal insulin by 10-20% when hypoglycemia occurs or when glucose values trend toward the lower end of target range 1
Reduce Lantus by 2-4 units (approximately 10-15% reduction) when fasting/overnight glucose values are consistently <80 mg/dL to prevent hypoglycemia 1

For a patient with type 1 diabetes, typical total daily insulin requirements range from 0.4-1.0 units/kg/day, with 0.5 units/kg/day being typical for metabolically stable patients 2, 1
Basal insulin should comprise approximately 40-60% of total daily dose in type 1 diabetes on multiple daily injection regimens 2, 3

A 1:10 carb ratio (1 unit per 10 grams carbohydrate) is reasonable and should be maintained initially 2
After adjusting basal insulin, reassess prandial coverage based on 2-hour postprandial glucose values 2

Check fasting blood glucose daily during the titration phase 1
Monitor for hypoglycemia symptoms, particularly during sleep (night sweats, vivid dreams, morning headaches) 4
Reassess basal insulin dose every 3 days after making changes 1
Target fasting glucose of 80-130 mg/dL, but aim for the middle of this range (100-110 mg/dL) given low BMI and hypoglycemia risk 1

Lower weight patients are more sensitive to insulin and at higher risk for hypoglycemia 1
The European Association for the Study of Diabetes recommends using the lower end of dosing ranges for patients with higher hypoglycemia risk 1
Consider whether inadequate caloric intake or weight loss is contributing to lower insulin requirements 4

Patients with hypoglycemia unawareness should increase glycemic targets for several weeks to partially reverse the condition 4
Educate on situations that increase hypoglycemia risk: fasting for tests/procedures, during or after exercise, and during sleep 4
Severe or frequent hypoglycemia is an absolute indication for treatment regimen modification 4
The American Diabetes Association emphasizes that providers should be vigilant in preventing hypoglycemia and should not aggressively attempt near-normal HbA1c levels in patients where such targets cannot be safely reached 4

If you experience hypoglycemia at specific times despite dose reduction, consider whether Lantus is providing adequate 24-hour coverage or if twice-daily dosing might be needed 3
Some patients require twice-daily glargine dosing when once-daily administration fails to provide full 24-hour coverage without causing hypoglycemia at specific times 3

Consistently low overnight glucose values (even if technically in range at 76 mg/dL) indicate excessive basal insulin and will eventually lead to nocturnal hypoglycemia 4, 1
Failure to reduce basal insulin when fasting glucose approaches 80 mg/dL in an underweight patient is a setup for severe hypoglycemia 1
The goal is not just to avoid documented hypoglycemia but to maintain a safety margin that prevents it 4

Reduce Lantus to 21-23 units and reassess fasting glucose after 3 days 1
If fasting glucose rises to 100-130 mg/dL range, this dose is appropriate 1
If fasting glucose remains <80 mg/dL, make an additional 2-unit reduction 1
Once basal insulin is optimized (consistent fasting glucose 100-130 mg/dL), evaluate whether prandial insulin coverage with your 1:10 ratio is adequate based on postprandial glucose values 2, 1